Candidate drugs are analysed by substructure to determine functional and cytotoxic residues, selective and non-selective binding sites. Such insight can be used to produce and screen multiple sub-generations of improved derivate compounds.
Candidate drugs are analysed by substructure to determine functional and cytotoxic residues, selective and non-selective binding sites. Such insight can be used to produce and screen multiple sub-generations of improved derivate compounds.
